The 50 L bioreactor extends the company’s portfolio of single-use processing systems from cell culture to ultrafiltration/diafiltration.
Merck Millipore says Mobius SensorReady technology monitors and controls the 50 L bioreactor, offering the flexibility to configure process monitoring at the point of use, reducing the need to customise bioreactor process containers and enabling easy integration of new sensor technologies.
The bioreactor process container features a rigid base and top panel design for simple, reliable and robust installation.
The Mobius CellReady Bioreactor system is available as a turnkey system complete with Finesse automation or as a modular system that can be integrated with a customer’s platform of choice.
‘The Mobius CellReady 50 L bioreactor is an important addition to the Mobius family. We’ve integrated a number of innovative features that deliver ease of use, reliability and operational flexibility compared with existing single-use systems,’ said Paul Chapman, vice president of Biopharm Process Solutions.
‘With this introduction, biopharmaceutical manufacturers now have a wider range of scalable single-use bioreactors offered by Merck Millipore, from three litres to 200 litres, to support their needs from process development to clinical scale.’
